GENECAPS
Live / Applied — Fourth extension granted (statement of use) (as of 19 Nov 2025)
What this means for you
Not registered yet, but its 21 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97373693
- Mark type
- Stylized text
- Filed
- 21 Apr 2022
- Published for opposition
- 24 Oct 2023
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Non-viral vectors in the form of nanoscale matrices, namely, pharmaceutical preparations for the delivery of therapeutic agents for the treatment or prevention of diseases affecting the immune system or hematologic system; Non-viral vectors, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Owner
- CSL Behring Gene Therapy, Inc., Pasadena, CA, US
- CSL Behring Gene Therapy, Inc., Pasadena, CA, US
Prosecution history
- 20 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Nov 2025 — SOU EXTENSION 4 GRANTED
- 19 Nov 2025 — SOU EXTENSION 4 FILED
- 19 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 20 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2025 — SOU EXTENSION 3 GRANTED
- 19 May 2025 — SOU EXTENSION 3 FILED
- 19 May 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Feb 2025 — SOU EXTENSION 2 GRANTED
- 19 Nov 2024 — SOU EXTENSION 2 FILED
- 15 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 16 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 May 2024 — SOU EXTENSION 1 GRANTED